Benefit of Adjuvant Abemaciclib Continues to Deepen at Longer Follow-Up
With additional follow-up, the benefit of adjuvant abemaciclib for patients with HR-positive/HER2-negative, node-positive, high-risk early breast cancer continues to deepen in magnitude afte...